High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High Expression of Somatostatin Receptors 2A, 3, and 5 in Corticotroph Pituitary Adenoma
Authors
Keywords
-
Journal
International Journal of Endocrinology
Volume 2018, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2018-12-10
DOI
10.1155/2018/1763735
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
- (2018) André Lacroix et al. Lancet Diabetes & Endocrinology
- Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target
- (2017) Saman Sizdahkhani et al. Scientific Reports
- PREDICTORS OF BIOCHEMICAL REMISSION AND RECURRENCE AFTER SURGICAL AND RADIATION TREATMENTS OF CUSHING DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
- (2016) Abd Moain Abu Dabrh et al. Endocrine Practice
- The Treatment of Cushing's Disease
- (2015) Rosario Pivonello et al. ENDOCRINE REVIEWS
- The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease
- (2015) K. Hayashi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
- (2015) Donato Iacovazzo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The role of bilateral adrenalectomy in the treatment of refractory Cushing's disease
- (2015) Anni Wong et al. Neurosurgical Focus
- Bilateral adrenalectomy for Cushing’s disease
- (2015) Laurence Katznelson Pituitary
- Peptide Receptor Radionuclide Therapy in Patients with Inoperable Meningiomas: Our Experience and Review of the Literature
- (2014) Fabio Minutoli et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Treatment of Cushing's disease: a mechanistic update
- (2014) Daniel Cuevas-Ramos et al. JOURNAL OF ENDOCRINOLOGY
- Update on radiation therapy in patients with Cushing’s disease
- (2014) Nicholas A. Tritos et al. Pituitary
- Somatostatin receptors: From signaling to clinical practice
- (2013) Marily Theodoropoulou et al. FRONTIERS IN NEUROENDOCRINOLOGY
- An Open-Label Dose-Escalation Study of Once-Daily and Twice-Daily Pasireotide in Healthy Volunteers
- (2012) Magdy Shenouda et al. AMERICAN JOURNAL OF THERAPEUTICS
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas
- (2010) Simona Grozinsky-Glasberg et al. CANCER
- Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature
- (2010) R. N. Clayton et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Medical Treatment of Cushing’s Disease: Somatostatin Analogues and Pasireotide
- (2010) Alberto M. Pedroncelli NEUROENDOCRINOLOGY
- Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases
- (2009) L. Righi et al. ANNALS OF ONCOLOGY
- Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
- (2009) Christiaan de Bruin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
- (2008) M. Boscaro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started